Brain neutral lipids mass is increased in α‐synuclein gene‐ablated mice

Because α‐synuclein (Snca) has a role in brain lipid metabolism, we determined the impact that Snca deletion had on whole brain lipid composition. We analysed masses of individual phospholipid (PL) classes and neutral lipid mass as well as PL acyl chain composition in brains from wild‐type and Snca‐...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neurochemistry 2007-04, Vol.101 (1), p.132-141
Hauptverfasser: Barceló‐Coblijn, Gwendolyn, Golovko, Mikhail Y., Weinhofer, Isabella, Berger, Johannes, Murphy, Eric J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 141
container_issue 1
container_start_page 132
container_title Journal of neurochemistry
container_volume 101
creator Barceló‐Coblijn, Gwendolyn
Golovko, Mikhail Y.
Weinhofer, Isabella
Berger, Johannes
Murphy, Eric J.
description Because α‐synuclein (Snca) has a role in brain lipid metabolism, we determined the impact that Snca deletion had on whole brain lipid composition. We analysed masses of individual phospholipid (PL) classes and neutral lipid mass as well as PL acyl chain composition in brains from wild‐type and Snca‐/‐ mice. Although total brain PL mass was not altered, cardiolipin and phosphatidylglycerol mass decreased 16% and 27%, respectively, in Snca‐/‐ mice. In addition, no changes were observed in plasmalogen or polyphosphoinositide mass. In ethanolamine glycerophospholipids and phosphatidylserine, docosahexaenoic acid (22 : 6n‐3) was decreased 7%, while 16 : 0 was increased 1.1‐fold and 1.4‐fold, respectively. Surprisingly, brain cholesterol, cholesteryl ester, and triacylglycerol mass were increased 1.1‐fold, 1.6‐fold, and 1.4‐fold, respectively in Snca‐/‐ mice. In isolated myelin, cholesterol mass was also increased 1.3‐fold, but because there was also a net increase in myelin PL mass, the cholesterol to PL ratio was unaltered. No changes in the expression of cholesterogenic enzymes were observed, suggesting these did not account for the observed changes in cholesterol. These data extend our previous results in astrocytes and kinetic studies in vivo demonstrating a role for Snca in brain lipid metabolism and demonstrate a clear impact on brain neutral lipid metabolism.
doi_str_mv 10.1111/j.1471-4159.2006.04348.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70330675</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70330675</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3978-d8900b53841c03f8c10688715e8c8028ee9f262c9c0a72d5bd420cd12de717103</originalsourceid><addsrcrecordid>eNqNkEtu2zAQQIkiReMkvUKgTbOTOvxIpBZZNEabtDDaTbImaHIU0KBkh7TQeNcj9Cq9SA-Rk4SqjWYbggCHM2_IwSOkoFDRvD6uKiokLQWt24oBNBUILlT1-IbM_heOyAyAsZKDYMfkJKUVAG1EQ9-RYypZDY1qZmRxFY0figHHbTShCH7jXSp6k1Lh8x5sRJPQ5aj4--fp1--0G0YbMF_vccCcMMtgthnovcUz8rYzIeH7w3lK7r58vp3flIsf11_nnxal5a1UpVMtwLLmSlALvFOW5lmUpDUqq4ApxLZjDbOtBSOZq5dOMLCOMoeSSgr8lFzs393E9cOIaat7nyyGYAZcj0lL4BwaWWdQ7UEb1ylF7PQm-t7EnaagJ5N6pSdhehKmJ5P6n0n9mFvPD3-Myx7dS-NBXQY-HACTrAldNIP16YVTDXAGKnOXe-6nD7h79QD62_f5FPFnFl6QBw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70330675</pqid></control><display><type>article</type><title>Brain neutral lipids mass is increased in α‐synuclein gene‐ablated mice</title><source>MEDLINE</source><source>Wiley Journals</source><source>IngentaConnect Free/Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library (Open Access Collection)</source><source>Free Full-Text Journals in Chemistry</source><creator>Barceló‐Coblijn, Gwendolyn ; Golovko, Mikhail Y. ; Weinhofer, Isabella ; Berger, Johannes ; Murphy, Eric J.</creator><creatorcontrib>Barceló‐Coblijn, Gwendolyn ; Golovko, Mikhail Y. ; Weinhofer, Isabella ; Berger, Johannes ; Murphy, Eric J.</creatorcontrib><description>Because α‐synuclein (Snca) has a role in brain lipid metabolism, we determined the impact that Snca deletion had on whole brain lipid composition. We analysed masses of individual phospholipid (PL) classes and neutral lipid mass as well as PL acyl chain composition in brains from wild‐type and Snca‐/‐ mice. Although total brain PL mass was not altered, cardiolipin and phosphatidylglycerol mass decreased 16% and 27%, respectively, in Snca‐/‐ mice. In addition, no changes were observed in plasmalogen or polyphosphoinositide mass. In ethanolamine glycerophospholipids and phosphatidylserine, docosahexaenoic acid (22 : 6n‐3) was decreased 7%, while 16 : 0 was increased 1.1‐fold and 1.4‐fold, respectively. Surprisingly, brain cholesterol, cholesteryl ester, and triacylglycerol mass were increased 1.1‐fold, 1.6‐fold, and 1.4‐fold, respectively in Snca‐/‐ mice. In isolated myelin, cholesterol mass was also increased 1.3‐fold, but because there was also a net increase in myelin PL mass, the cholesterol to PL ratio was unaltered. No changes in the expression of cholesterogenic enzymes were observed, suggesting these did not account for the observed changes in cholesterol. These data extend our previous results in astrocytes and kinetic studies in vivo demonstrating a role for Snca in brain lipid metabolism and demonstrate a clear impact on brain neutral lipid metabolism.</description><identifier>ISSN: 0022-3042</identifier><identifier>EISSN: 1471-4159</identifier><identifier>DOI: 10.1111/j.1471-4159.2006.04348.x</identifier><identifier>PMID: 17250686</identifier><identifier>CODEN: JONRA9</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>alpha-Synuclein - genetics ; Animals ; Biochemistry and metabolism ; Biological and medical sciences ; Brain - metabolism ; Brain Chemistry - genetics ; Cardiolipins - metabolism ; Central nervous system ; cholesterol ; Cholesterol - metabolism ; cholesteryl esters ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Fundamental and applied biological sciences. Psychology ; Gene Expression Regulation, Enzymologic - physiology ; Lipid Metabolism - genetics ; Medical sciences ; Membrane Lipids - metabolism ; Mice ; Mice, Knockout ; Myelin Sheath - metabolism ; Neurology ; Phosphatidylglycerols - metabolism ; Phospholipids - metabolism ; triacylglycerols ; Triglycerides - metabolism ; Vertebrates: nervous system and sense organs ; α‐synuclein</subject><ispartof>Journal of neurochemistry, 2007-04, Vol.101 (1), p.132-141</ispartof><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3978-d8900b53841c03f8c10688715e8c8028ee9f262c9c0a72d5bd420cd12de717103</citedby><cites>FETCH-LOGICAL-c3978-d8900b53841c03f8c10688715e8c8028ee9f262c9c0a72d5bd420cd12de717103</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1471-4159.2006.04348.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1471-4159.2006.04348.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18603208$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17250686$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Barceló‐Coblijn, Gwendolyn</creatorcontrib><creatorcontrib>Golovko, Mikhail Y.</creatorcontrib><creatorcontrib>Weinhofer, Isabella</creatorcontrib><creatorcontrib>Berger, Johannes</creatorcontrib><creatorcontrib>Murphy, Eric J.</creatorcontrib><title>Brain neutral lipids mass is increased in α‐synuclein gene‐ablated mice</title><title>Journal of neurochemistry</title><addtitle>J Neurochem</addtitle><description>Because α‐synuclein (Snca) has a role in brain lipid metabolism, we determined the impact that Snca deletion had on whole brain lipid composition. We analysed masses of individual phospholipid (PL) classes and neutral lipid mass as well as PL acyl chain composition in brains from wild‐type and Snca‐/‐ mice. Although total brain PL mass was not altered, cardiolipin and phosphatidylglycerol mass decreased 16% and 27%, respectively, in Snca‐/‐ mice. In addition, no changes were observed in plasmalogen or polyphosphoinositide mass. In ethanolamine glycerophospholipids and phosphatidylserine, docosahexaenoic acid (22 : 6n‐3) was decreased 7%, while 16 : 0 was increased 1.1‐fold and 1.4‐fold, respectively. Surprisingly, brain cholesterol, cholesteryl ester, and triacylglycerol mass were increased 1.1‐fold, 1.6‐fold, and 1.4‐fold, respectively in Snca‐/‐ mice. In isolated myelin, cholesterol mass was also increased 1.3‐fold, but because there was also a net increase in myelin PL mass, the cholesterol to PL ratio was unaltered. No changes in the expression of cholesterogenic enzymes were observed, suggesting these did not account for the observed changes in cholesterol. These data extend our previous results in astrocytes and kinetic studies in vivo demonstrating a role for Snca in brain lipid metabolism and demonstrate a clear impact on brain neutral lipid metabolism.</description><subject>alpha-Synuclein - genetics</subject><subject>Animals</subject><subject>Biochemistry and metabolism</subject><subject>Biological and medical sciences</subject><subject>Brain - metabolism</subject><subject>Brain Chemistry - genetics</subject><subject>Cardiolipins - metabolism</subject><subject>Central nervous system</subject><subject>cholesterol</subject><subject>Cholesterol - metabolism</subject><subject>cholesteryl esters</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene Expression Regulation, Enzymologic - physiology</subject><subject>Lipid Metabolism - genetics</subject><subject>Medical sciences</subject><subject>Membrane Lipids - metabolism</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>Myelin Sheath - metabolism</subject><subject>Neurology</subject><subject>Phosphatidylglycerols - metabolism</subject><subject>Phospholipids - metabolism</subject><subject>triacylglycerols</subject><subject>Triglycerides - metabolism</subject><subject>Vertebrates: nervous system and sense organs</subject><subject>α‐synuclein</subject><issn>0022-3042</issn><issn>1471-4159</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkEtu2zAQQIkiReMkvUKgTbOTOvxIpBZZNEabtDDaTbImaHIU0KBkh7TQeNcj9Cq9SA-Rk4SqjWYbggCHM2_IwSOkoFDRvD6uKiokLQWt24oBNBUILlT1-IbM_heOyAyAsZKDYMfkJKUVAG1EQ9-RYypZDY1qZmRxFY0figHHbTShCH7jXSp6k1Lh8x5sRJPQ5aj4--fp1--0G0YbMF_vccCcMMtgthnovcUz8rYzIeH7w3lK7r58vp3flIsf11_nnxal5a1UpVMtwLLmSlALvFOW5lmUpDUqq4ApxLZjDbOtBSOZq5dOMLCOMoeSSgr8lFzs393E9cOIaat7nyyGYAZcj0lL4BwaWWdQ7UEb1ylF7PQm-t7EnaagJ5N6pSdhehKmJ5P6n0n9mFvPD3-Myx7dS-NBXQY-HACTrAldNIP16YVTDXAGKnOXe-6nD7h79QD62_f5FPFnFl6QBw</recordid><startdate>200704</startdate><enddate>200704</enddate><creator>Barceló‐Coblijn, Gwendolyn</creator><creator>Golovko, Mikhail Y.</creator><creator>Weinhofer, Isabella</creator><creator>Berger, Johannes</creator><creator>Murphy, Eric J.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200704</creationdate><title>Brain neutral lipids mass is increased in α‐synuclein gene‐ablated mice</title><author>Barceló‐Coblijn, Gwendolyn ; Golovko, Mikhail Y. ; Weinhofer, Isabella ; Berger, Johannes ; Murphy, Eric J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3978-d8900b53841c03f8c10688715e8c8028ee9f262c9c0a72d5bd420cd12de717103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>alpha-Synuclein - genetics</topic><topic>Animals</topic><topic>Biochemistry and metabolism</topic><topic>Biological and medical sciences</topic><topic>Brain - metabolism</topic><topic>Brain Chemistry - genetics</topic><topic>Cardiolipins - metabolism</topic><topic>Central nervous system</topic><topic>cholesterol</topic><topic>Cholesterol - metabolism</topic><topic>cholesteryl esters</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene Expression Regulation, Enzymologic - physiology</topic><topic>Lipid Metabolism - genetics</topic><topic>Medical sciences</topic><topic>Membrane Lipids - metabolism</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>Myelin Sheath - metabolism</topic><topic>Neurology</topic><topic>Phosphatidylglycerols - metabolism</topic><topic>Phospholipids - metabolism</topic><topic>triacylglycerols</topic><topic>Triglycerides - metabolism</topic><topic>Vertebrates: nervous system and sense organs</topic><topic>α‐synuclein</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Barceló‐Coblijn, Gwendolyn</creatorcontrib><creatorcontrib>Golovko, Mikhail Y.</creatorcontrib><creatorcontrib>Weinhofer, Isabella</creatorcontrib><creatorcontrib>Berger, Johannes</creatorcontrib><creatorcontrib>Murphy, Eric J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of neurochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Barceló‐Coblijn, Gwendolyn</au><au>Golovko, Mikhail Y.</au><au>Weinhofer, Isabella</au><au>Berger, Johannes</au><au>Murphy, Eric J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Brain neutral lipids mass is increased in α‐synuclein gene‐ablated mice</atitle><jtitle>Journal of neurochemistry</jtitle><addtitle>J Neurochem</addtitle><date>2007-04</date><risdate>2007</risdate><volume>101</volume><issue>1</issue><spage>132</spage><epage>141</epage><pages>132-141</pages><issn>0022-3042</issn><eissn>1471-4159</eissn><coden>JONRA9</coden><abstract>Because α‐synuclein (Snca) has a role in brain lipid metabolism, we determined the impact that Snca deletion had on whole brain lipid composition. We analysed masses of individual phospholipid (PL) classes and neutral lipid mass as well as PL acyl chain composition in brains from wild‐type and Snca‐/‐ mice. Although total brain PL mass was not altered, cardiolipin and phosphatidylglycerol mass decreased 16% and 27%, respectively, in Snca‐/‐ mice. In addition, no changes were observed in plasmalogen or polyphosphoinositide mass. In ethanolamine glycerophospholipids and phosphatidylserine, docosahexaenoic acid (22 : 6n‐3) was decreased 7%, while 16 : 0 was increased 1.1‐fold and 1.4‐fold, respectively. Surprisingly, brain cholesterol, cholesteryl ester, and triacylglycerol mass were increased 1.1‐fold, 1.6‐fold, and 1.4‐fold, respectively in Snca‐/‐ mice. In isolated myelin, cholesterol mass was also increased 1.3‐fold, but because there was also a net increase in myelin PL mass, the cholesterol to PL ratio was unaltered. No changes in the expression of cholesterogenic enzymes were observed, suggesting these did not account for the observed changes in cholesterol. These data extend our previous results in astrocytes and kinetic studies in vivo demonstrating a role for Snca in brain lipid metabolism and demonstrate a clear impact on brain neutral lipid metabolism.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>17250686</pmid><doi>10.1111/j.1471-4159.2006.04348.x</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3042
ispartof Journal of neurochemistry, 2007-04, Vol.101 (1), p.132-141
issn 0022-3042
1471-4159
language eng
recordid cdi_proquest_miscellaneous_70330675
source MEDLINE; Wiley Journals; IngentaConnect Free/Open Access Journals; EZB-FREE-00999 freely available EZB journals; Wiley Online Library (Open Access Collection); Free Full-Text Journals in Chemistry
subjects alpha-Synuclein - genetics
Animals
Biochemistry and metabolism
Biological and medical sciences
Brain - metabolism
Brain Chemistry - genetics
Cardiolipins - metabolism
Central nervous system
cholesterol
Cholesterol - metabolism
cholesteryl esters
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Fundamental and applied biological sciences. Psychology
Gene Expression Regulation, Enzymologic - physiology
Lipid Metabolism - genetics
Medical sciences
Membrane Lipids - metabolism
Mice
Mice, Knockout
Myelin Sheath - metabolism
Neurology
Phosphatidylglycerols - metabolism
Phospholipids - metabolism
triacylglycerols
Triglycerides - metabolism
Vertebrates: nervous system and sense organs
α‐synuclein
title Brain neutral lipids mass is increased in α‐synuclein gene‐ablated mice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T02%3A09%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Brain%20neutral%20lipids%20mass%20is%20increased%20in%20%CE%B1%E2%80%90synuclein%20gene%E2%80%90ablated%20mice&rft.jtitle=Journal%20of%20neurochemistry&rft.au=Barcel%C3%B3%E2%80%90Coblijn,%20Gwendolyn&rft.date=2007-04&rft.volume=101&rft.issue=1&rft.spage=132&rft.epage=141&rft.pages=132-141&rft.issn=0022-3042&rft.eissn=1471-4159&rft.coden=JONRA9&rft_id=info:doi/10.1111/j.1471-4159.2006.04348.x&rft_dat=%3Cproquest_cross%3E70330675%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70330675&rft_id=info:pmid/17250686&rfr_iscdi=true